期刊
JOURNAL OF BIOETHICAL INQUIRY
卷 17, 期 4, 页码 555-561出版社
SPRINGER
DOI: 10.1007/s11673-020-10013-y
关键词
COVID-19; Pandemic; Research quality; Research governance; Research integrity; Biomedical publication
In response to the COVID-19 pandemic, there has been a rapid growth in research focused on developing vaccines and therapies. In this context, the need for speed is taken for granted, and the scientific process has adapted to accommodate this. On the surface, attempts to speed up the research enterprise appear to be a good thing. It is, however, important to consider what, if anything, might be lost when biomedical innovation is sped up. In this article we use the case of a study recently retracted from theLancetto illustrate the potential risks and harms associated with speeding up science. We then argue that, with appropriate governance mechanisms in place (and adequately resourced), it should be quite possible to both speed up science and remain attentive to scientific quality and integrity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据